Survived
|
Blood glucose (mmol/l; median [range])
|
3.2 (0.7–3.4); NS
|
3.5 (1.5–3.9)
|
|
Blood glucose < lower limit (n [%])
|
47/85 (55%)*
|
24/92 (26%)
|
|
Episodes (median [range])
|
1 (1–6)
|
1 (1–11)
|
|
Time point of occurrence (%)
| | |
|
Week 1
|
55%*
|
28%
|
|
Week 2
|
24%
|
36%
|
|
Week 3
|
21%
|
36%
|
Died
|
Blood glucose (mmol/l; median [range])
|
2.7 (0.6–3.4); NS
|
3.7 (3.1–3.9)
|
|
Blood glucose < lower limit (n [%])
|
12/29 (41%)*
|
6/22 (27%)
|
|
Episodes (median [range])
|
1.5 (1–6)
|
1.5 (1–3)
|
|
Time point of occurrence (%)
| | |
|
Week 1
|
95%*
|
50%
|
|
Week 2
|
5%
|
30%
|
|
Week 3
|
0
|
20%
|